<b>Gapping down</b><br/><b>In reaction to disappointing earnings/guidance:</b> TITN -14.2%, WPRT -13.6%, BIOC -10.1%, KFY -8.8%, UNFI -8%, EGT -7.6%, RM -7.2%, VNET -5.8%, MR -4.8%, FENG -3.7%, LMNR -3.3%, ACRX -2.9%, PUK -2.3%, MUX -2%, AMCN -0.9%, PEB -0.9%, MVIS -0.8%<br/><br/><b>Select metals/mining stocks trading lower:</b> BHP -3.1%, FCX -2.1%, VALE -2.1%, MT -1.8%<br/><br/><b>Select oil/gas related names showing early weakness:</b> STO -4.1%, SDRL -3.1%, TOT -2.9%, RDS.A -2.2%, HAL -2%, BP -1.9%, RIG -1.6%<br/><br/><b>Other news: </b>ANV -41.5% (files voluntary, 'pre-arranged' chapter 11 cases; restructuring supported by majority of creditors and includes a cash injection of $78 million), CLMT -6.6% ( announces public offering of 6 mln common units), CPE -5.5% (prices 9,000,000 shares of its common stock for total estimated gross proceeds of ~$59 mln), CTIC -5% (pulling back following yday's strength), NDLS -4.9% (disclosed that on March 9, 2015, Dan Fogarty announced he has resigned as Executive Vice President of Marketing for personal reasons), ROSE -4.5% ( announces public offering of 12 mln common stock shares), EEP -4.2% (commenced an underwritten public offering of 8 mln of its Class A Common Units representing limited partner interests), ADHD -4.1% (announces its Phase II safety and tolerability study of a single administration of MDX in adolescent patients with ADHD achieved its primary endpoint), CNHI -4% (following TITN's guidance; TITN is largest distributor), MAIN -3.7% (announced plans to make a public offering of shares of common stock), MERU -3.1% (disclosed that on March 4, 2015, it entered into an Annual Meeting Agreement with Vertex Special Opportunities Fund), TTPH -2.8% (announced it intends to offer and sell up to 3.5 mln shares of its common stock in an underwritten public offering), CSIQ -2.8% (releases comments on European Commission Letter which raised potential issues concerning compliance with its undertaking agreement; co says any decision would not significantly impact FY15 guidance), BUD -2.4% (still checking), KYTH -2% (commenced an underwritten public offering of $125 million of shares of its common stock), MGM -2% (in sympathy with MPEL), TSEM -1.8% (will offer an acceleration mechanism to its existing Series F convertible bonds, available to all such holders, targeting a conversion of ~33% of its outstanding bonds), GAIN -1.7% (announces common stock offering of 3 mln shares of common stock), IMPV -1.3% (announces a proposed follow-on offering of 3 mln shares of its common stock)<br/><br/><b>Analyst comments</b>: ZIOP -6% (downgraded to Neutral from Buy at Mizuho), XON -4.6% (downgraded to Neutral from Buy at Mizuho), MPEL -3.2% (downgraded to Sell from Buy at Deutsche Bank), EA -2.9% (downgraded to Hold from Buy at Needham), LECO -2.4% (downgraded to Hold from Buy at BB&T Capital Mkts).<br/><br/><b>Gapping up</b><br/><b>In reaction to strong earnings/guidance: </b>WATT +19.1%, MM +6.9%, URBN +6.8%, XOXO +5.1%, QIHU +4.1%, VSTM +0.9%, RDUS +0.6%<br/><br/><b>M&A news: </b>BBNK +14.2% (to be acquired by Western Alliance Bancorporation (WAL))<br/><br/><b>Other news: </b>BONE +11.6% (signed a national distribution agreement with Spartan Medical), DARA +10.5% (announces the acquisition of exclusive North American rights to Oravig from Onxeo S.A.), RESN +9.3% (engaged with a second customer for the design of an RF filter utilizing its Infinite Synthesized Networks, or ISN technology), CS +6.3% (Brady Dougan to leave Credit Suisse as CEO; current Prudential (PUK) CEO Tidjane Thiam to become Chief Executive Officer of CS), MPO +5.2% (executed a Purchase and Sale Agreement with Pintail Oil and Gas for the sale of its Dequincy assets located in Beauregard and Calcasieu Parishes, Louisiana for total consideration of $44 mln), LL +4.2% (announced agenda for its business update conference call to be held on March 12, 2015 at 10am ET), RJET +4.1% (to replace MMS in the S&P SmallCap 600), RMGN +3.4% (cont strength), ORAN +3.1% (still checking), QCOM +2.3% ( announced increases in its capital return program), SWKS +1.9% (to replace PETM in the S&P 500), MRGE +1.7% (Guggenheim Capital disclosed a 10.9% active stake in 13D filing), MMS +1.5% (to replace SWKS in the S&P MidCap 400), NBG +1.5% (still checking), SGYP +1.3% (OrbiMedCapital discloses 13.57% passive stake in 13G filing)<br/><br/><b>Analyst comments:</b>SVU +2.1% (upgraded to Buy from Hold at Deutsche Bank), RDN +2% (initiated with a Buy at BTIG Research), ARRS +1% (upgraded to Overweight from Equal Weight at Barclays ), GG +0.8% (upgraded to Hold from Underperform at Jefferies), NVDA +0.6% (upgraded to Buy at BofA/Merrill)<br/><br/>Allikas:Briefing.com